Lazar David E. 13D/13G Filings for Cyclacel Pharmaceuticals, Inc. (CYCC)

Lazar David E. 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-28
4:46 pm
Purchase
2025-02-0613DCyclacel Pharmaceuticals, Inc.
CYCC
Lazar David E.39,021,180
15.840%
39,021,180increase
(New Position)
Filing